Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine

被引:23
作者
Frossard, Nelly [1 ]
Strolin-Benedetti, Margherita
Purohit, Ashok [2 ]
Pauli, Gabrielle [2 ]
机构
[1] Univ Louis Pasteur Strasbourg 1, Fac Pharm, Strasbourg, France
[2] Hop Lyautey, Serv Pneumol, Strasbourg, France
关键词
allergen; antihistamine; desloratadine; levocetirizine; pharmacokinetics; skin; wheal and flare reactions;
D O I
10.1111/j.1365-2125.2007.03009.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AIM To evaluate the inhibitory activity of the new-generation antihistamines levocetirizine and desloratadine at their therapeutic doses on the allergen-induced wheal and flare reaction at 1.5 h, 4 h, 7 h, 12 h and 24 h postdose, and to measure their plasma and skin concentrations. METHODS A double-blind, randomized, cross-over, placebo-controlled study in 18 allergic subjects was carried out. The time-response of the wheal and flare reaction areas under the curve (AUC) were compared by ANOVA. RESULTS Both antihistamines significantly (P < 0.001) inhibited the allergen-induced wheal and flare reactions compared with placebo. Levocetirizine was significantly more potent than desloratadine. Mean +/- SEM wheal AUC(0-24 h) was 506.4 +/- 81.0 with levocetirizine and 995.5 +/- 81.0 mm(2) h with desloratadine as compared with placebo (1318.5 +/- 361.0 mm(2) h). Flare AUC(0-24 h) was 5927.3 +/- 1686.5 and 15838.2 +/- 1686.5 mm(2) h, respectively [P < 0.001 for both compared with placebo (22508.2 +/- 7437.1 mm(2) h)]. Levocetirizine showed significant inhibition of wheal and flare already at 1.5 h postdose compared with placebo (P <= 0.001); desloratadine achieved a significant effect only after 4 h. The mean total plasma concentration at 12 h and 24 h after intake was higher for levocetirizine (58.1 +/- 13.4 and 20.0 +/- 8.1 ng ml(-1), respectively) as compared with desloratadine (0.82 +/- 0.24 and 0.45 +/- 0.16 ng ml(-1)). Similarly, higher mean unbound skin concentrations were observed for levocetirizine 24 h after intake (1.80 ng g(-1)) than for desloratadine (0.07 ng g(-1)). This was associated with greater receptor occupancy for levocetirizine (54%) than desloratadine (34%) at 24 h. CONCLUSIONS Levocetirizine suppressed the cutaneous allergic reactions with a higher potency than desloratadine, which correlated with its high receptor occupancy. Receptor occupancy rather than dry properties of desloratadine and levocetirizine in their skin activity wrug affinity or plasma half-life is more representative of antihistamine potency.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 22 条
[1]   Biochemical characterization of desloratadine, a potent antagonist of the human histamine H1 receptor [J].
Anthes, JC ;
Gilchrest, H ;
Richard, C ;
Eckel, S ;
Hesk, D ;
West, RE ;
Williams, SM ;
Greenfeder, S ;
Billah, M ;
Kreutner, W ;
Egan, RW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 449 (03) :229-237
[2]   Levocetirizine: the allergist's arsenal grows larger [J].
Bloebaum, RM ;
Grant, JA .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (07) :1581-1588
[3]   Blood distribution of levocetirizine, a new non-sedating histamine H1-receptor antagonist, in humans [J].
Bree, F ;
Thiault, L ;
Gautiers, G ;
Benedetti, MS ;
Baltes, E ;
Rihoux, JP ;
Tillement, JP .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (06) :471-478
[4]   Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: A pilot study [J].
Ciprandi, G ;
Cirillo, I ;
Vizzaccaro, A ;
Civardi, E ;
Barberi, S ;
Allen, M ;
Marseglia, GL .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (13-14) :1800-1808
[5]   Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin [J].
Denham, KJ ;
Boutsiouki, P ;
Clough, GR ;
Church, MK .
INFLAMMATION RESEARCH, 2003, 52 (10) :424-427
[6]  
Frossard N., 2003, Clinical and Experimental Allergy Reviews, V3, P87, DOI 10.1046/j.1472-9725.2003.00021.x
[7]   Duration of the antihistaminic effect after discontinuation of ebastine [J].
Frossard, N ;
Vital-Durand, D ;
Mounedji, N ;
Valleteau, A .
ALLERGY, 2001, 56 (06) :553-557
[8]   Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines [J].
Gillard, M ;
Benedetti, MS ;
Chatelain, P ;
Baltes, E .
INFLAMMATION RESEARCH, 2005, 54 (09) :367-369
[9]   H1 antagonists:: receptor affinity versus selectivity [J].
Gillard, M ;
Christophe, B ;
Wels, B ;
Peck, M ;
Massingham, R ;
Chatelain, P .
INFLAMMATION RESEARCH, 2003, 52 (Suppl 1) :S49-S50
[10]   Levocetirizine - A review of its use in the management of allergic rhinitis and skin allergies [J].
Hair, Philip I. ;
Scott, Lesley J. .
DRUGS, 2006, 66 (07) :973-996